For the science and health communities
A virtual special issue – and a Q&A with Dr. Peter Sarnow – shed light on new research to combat this “silent killer”
Elsevier supports the growing movement to require clinical trials to be registered and their results reported
The Supreme Court's decision to invalidate Myriad’s patents on the BRCA genes has wide-reaching ramifications for genetic testing and patients’ options
He talks about how the high cost of medicine is fueling the market for fake prescription drugs and posing serious risks for world health
The Reproducibility Initiative gets $1.3 million for a project that could enable the development of future therapies
How researchers develop drugs — and how PharmaPendium’s new Metabolizing Enzymes and Transporters module can help them make better decisions
QUOSA’s software helps information managers at pharma and biotech companies get content to the professionals who need it
Competition for academic research posts is fierce in the US, but alternative settings offer research opportunities in academia and beyond.
Copyright © Elsevier BV or its licensors or contributors
Cookies are set by this site. To decline them or learn more, visit our Cookies page.